This activity is designed for physicians, nurse practitioners, physician assistants and other healthcare professionals and aims to facilitate proactive discussions on liver cancer patients' diagnosis, treatment options, and postoperative outcomes, while also enhancing diagnostic methods, treatment options, and clinical trials. Additionally, it serves as an educational platform for medical professionals, with annual evaluations to assess and implement changes in practice to improve patient outcomes. This activity meets the Commission on Cancer Standards.

Course Director:

• Paul Schmeltzer, MD

  
Overall Objectives:

1. Analyze the execution of the NCCN (& LCI) Guidelines for all HCC cancer patients. 
2. Assess advanced information of available treatments to improve outcomes of the cancer patients. 
3. Apply the AASLD guidelines for HCC patients.

Target Audience:  
This activity is designed for physicians, and other healthcare professionals.

Accreditation Statement

In support of improving patient care, Advocate Health is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Statement(s)

American Medical Association (AMA) 
Advocate Health designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Board Recognition Statement(s)

American Board of Surgery (ABS)
Successful completion of this CME activity enables the learner to earn credit toward the CME requirement of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.